Africa: Global Strategy to End Cryptococcal Meningitis in People Living With HIV
[spotlight] Cryptococcal meningitis is the second biggest killer of people living with HIV after tuberculosis (TB). For decades it has flown under the radar - despite its high mortality rate - but it is finally getting the attention it deserves with the launch of a new global initiative to end deaths due to this fungal brain infection by 2030. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - June 8, 2021 Category: Infectious Diseases Source Type: news

16 Candles? Time for Your Meningitis Shot, Molly Ringwald Says
MONDAY, May 24, 2021 -- Leslie Maier lost her son, Chris, to meningococcal meningitis more than 15 years ago, but by telling his story she hopes to educate other parents about this rare but potentially deadly illness that a vaccine can... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 24, 2021 Category: General Medicine Source Type: news

16 Candles? Time for Your Meningitis Shot, Molly Ringwald Says
Title: 16 Candles? Time for Your Meningitis Shot, Molly Ringwald SaysCategory: Health NewsCreated: 5/24/2021 12:00:00 AMLast Editorial Review: 5/24/2021 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - May 24, 2021 Category: Pediatrics Source Type: news

Infants With UTI: No Increased Risk of Bacterial Meningitis Infants With UTI: No Increased Risk of Bacterial Meningitis
The decision to perform a spinal tap procedure in infants to determine whether they have bacterial meningitis should not be guided by abnormal urinalysis results alone, according to new research.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - May 18, 2021 Category: Infectious Diseases Tags: Pediatrics News Source Type: news

Teens Ages 12 to 15 Should Get Pfizer-BioNTech ’s COVID-19 Vaccine, Says a CDC Expert Panel
Following the US Food and Drug Administration’s decision on May 10 to extend emergency use authorization for the Pfizer-BioNTech vaccine to include 12- to 15-year olds, the Centers for Disease Control added its recommendation that teens in that age group should be vaccinated with the shot. The expert panel of the CDC’s Advisory Committee on Immunization Practices makes immunization recommendations, and determined that based on the evidence from a study of more than 2200 teens conducted by Pfizer-BioNTech, that the vaccine was safe and effective. During the day-long meeting, however, the members discussed whethe...
Source: TIME: Health - May 13, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Nigeria: Kano State Created a Budget Line for Epidemic Preparedness
[Nigeria Health Watch] The health security of a nation comprises the activities that lessen adverse public health incidents and ensures a healthy and productive population. It is vital to developing strong and resilient health systems that can prevent, detect, and respond to infectious disease threats, wherever they occur. Nigeria has experienced outbreaks of infectious diseases such as Lassa fever, cerebrospinal meningitis, Ebola, COVID-19 and resurgences of yellow fever and monkeypox. The Ebola outbreak in the West African Dem (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 11, 2021 Category: African Health Source Type: news

The Most Important Thing Rich Countries Can Do to Help India Fight COVID-19
The Biden Administration is debating whether COVID-19 vaccine patents should be temporarily waived, given the devastating humanitarian crisis unfolding in India from the virus. There are two key factors that should drive the Biden team to agree to do so: first, there is strong precedent on waiving patents in the context of public health emergencies; second, the real-world effectiveness of most COVID-19 vaccines against symptomatic disease and transmission can temper the disaster. The Biden Administration will be making its decision on lifting some patent restrictions as early as May 5. India faces a catastrophe, with ove...
Source: TIME: Health - May 5, 2021 Category: Consumer Health News Authors: Dr. Monica Gandhi Tags: Uncategorized COVID-19 India Source Type: news

With Covid Vaccines for Teens and Kids, Timing Matters
There can be a seven- or eight-week window around Covid vaccines when other shots can ’t be given, so those who need them for camp, school or sports have to plan ahead. (Source: NYT Health)
Source: NYT Health - May 4, 2021 Category: Consumer Health News Authors: Perri Klass, M.D. Tags: Vaccination and Immunization Pediatric Inflammatory Multisystem Syndrome (PIMS) Coronavirus Risks and Safety Concerns Meningitis Youth Teenagers and Adolescence Children and Childhood Source Type: news

What Are Some Etiologies for Intellectual Disability?
Discussion “Intellectual disability (ID) is a neurodevelopmental disorder that is characterized by deficits in both intellectual functioning and adaptive function whose onset is in the development period.” Global developmental delay (GDD) is used to describe children from 0-5 years old with significant delays in 2 or more developmental areas. These delays may be transient but up to 2/3 of children with GDD will have ID. Overall 1-3% of the general population has ID which makes it very common. Most children with GDD/ID are identified because of delays in meeting milestones or general academic achievement. ID pat...
Source: PediatricEducation.org - May 3, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Study shows how meningitis-causing bacteria may sense fever to avoid immune killing
(Karolinska Institutet) Researchers at Karolinska Institutet in Sweden have discovered a mechanism through which meningitis-causing bacteria can evade our immune system. In laboratory tests, they found that Streptococcus pneumoniae and Haemophilus influenzae respond to increasing temperatures by producing safeguards that keep them from getting killed. This may prime their defenses against our immune system and increase their chances of survival, the researchers say. The findings are published in the journal PLoS Pathogens. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 29, 2021 Category: Infectious Diseases Source Type: news

Nick Springer, Paralympic Gold Medalist, Dies at 35
A quadruple amputee, he was a relentless defender on the United States ’ wheelchair rugby team, which won a gold medal at the 2008 Paralympics in Beijing. (Source: NYT Health)
Source: NYT Health - April 23, 2021 Category: Consumer Health News Authors: Richard Sandomir Tags: Springer, Nick Deaths (Obituaries) Disabilities Rugby Meningococcal Meningitis Paralympic Games Wheelchair Rugby Source Type: news

Babies surviving Group B strep more likely to require special educational support
(London School of Hygiene& Tropical Medicine) Invasive Group B Streptococcus (GBS) disease, notably meningitis, during the first days and months of a baby's life can have persistent effects for children and hence their families, according to new research. Published in the Lancet Child& Adolescent Health, the study is the first evidence of long-term effects including after GBS sepsis (infection in the bloodstream). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 21, 2021 Category: Infectious Diseases Source Type: news

Meningitis epidemics could be forewarned by weather forecasts in sub-Saharan Africa
A pilot is under way to harness forecasts to predict where conditions that fuel cases are likely to developA weather-based surveillance system that could offer advanced warning of outbreaks of meningitis is being piloted across sub-Saharan Africa in a bid to save lives, researchers have revealed.According to the Meningitis Research Foundation, meningitis affectsabout 5 million people around the world each year, one in 10 of whom die, while two in 10 are left with lasting impacts, such as brain damage.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 12, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Meningitis Africa Health World news Meteorology Science Source Type: news

Sub-Saharan meningitis epidemics could be signalled by weather forecasts
Pilot scheme is under way to harness forecasts to predict where conditions that fuel cases are likely to developA weather-based surveillance system that could offer advanced warning of outbreaks of meningitis is being piloted across sub-Saharan Africa in a bid to save lives, researchers have revealed.According to the Meningitis Research Foundation, meningitis affectsabout 5 million people around the world each year, one in 10 of whom die, while two in 10 are left with lasting impacts, such as brain damage.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 12, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Meningitis Africa Health World news Meteorology Science Source Type: news

WHO recommends CAD with chest x-rays to fight tuberculosis
The World Health Organization (WHO) has updated its recommendations for tuberculosi...Read more on AuntMinnie.comRelated Reading: AI-based CAD accurately detects tuberculosis on chest x-rays Are studies on AI for tuberculosis really valid? FDG-PET/CT helps predict tuberculosis relapse PET shows efficacy of tuberculosis meningitis drug Portable automated x-ray system targets tuberculosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 24, 2021 Category: Radiology Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

U.S. Will Have Enough COVID-19 Vaccines for All Adults by End of May, Biden Says
(WASHINGTON) — President Joe Biden said Tuesday that the U.S. expects to take delivery of enough coronavirus vaccines for all adult Americans by the end of May, two months earlier than anticipated, as his administration announced that drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved shot. With the bolstered supply, Biden also announced he would be using the powers of the federal government to direct all states to prioritize vaccinating teachers, and said the federal government would provide the doses directly through its pharmacy program. He challenged states to administe...
Source: TIME: Health - March 2, 2021 Category: Consumer Health News Authors: ZEKE MILLER, LINDA A. JOHNSON and JONATHAN LEMIRE/AP Tags: Uncategorized COVID-19 wire Source Type: news

ACIP Releases 2021 Child/Adolescent Vaccine Schedule ACIP Releases 2021 Child/Adolescent Vaccine Schedule
Changes include new recommendations on the influenza and meningococcal vaccines and guidance on COVID-19 vaccines.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2021 Category: Consumer Health News Tags: Pediatrics News Alert Source Type: news

Can AstraZeneca ’s Vaccine Prevent the Spread of COVID-19 Virus?
In a new—yet to be peer-reviewed—study, the pharmaceutical company AstraZeneca and its partners at the University of Oxford report that their COVID-19 shot may not only protect against disease but also help to prevent spread of the SARS-CoV-2 virus. The news was heralded by policy makers desperate to see a vaccine that can curb spread of the disease, but scientists have been a bit more cautious. If confirmed, the results would represent a breakthrough in the COVID-19 vaccine race. So far, the shots authorized or approved around the world have shown strong protection against moderate to severe disease, but haven...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

What Causes Lethargy?
Discussion Lethargy is a common word used to describe a person who is drowsy, sluggish, listless and apathetic. Concentration may be difficult and they may have problems doing simple tasks. Many people actual mean fatigue or lassitude or being more tired when they use the word. In medical terms, lethargy is usually used to describe patients who have some type of excessive tiredness and usually have mental status changes with decreased alertness or arousal. Patients and health care providers both usually qualify the term and give more description to better communicate what is implied when using the term. This is true of man...
Source: PediatricEducation.org - January 25, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Research establishes antibiotic potential for cannabis molecule
(University of Queensland) The main nonpsychoactive component of cannabis has been shown to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease, which could lead to the first new class of antibiotics for resistant bacteria in 60 years. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 19, 2021 Category: Infectious Diseases Source Type: news

Suzi Perry health: Sports host's 'horrendous' symptoms of meningitis
SUZI PERRY made her mark hosting the BBC's Gadget Show and MotoGP. With more than two decades on the box, the Shropshire born presenter has had her fair trials of ill health. (Source: Daily Express - Health)
Source: Daily Express - Health - January 17, 2021 Category: Consumer Health News Source Type: news

Mother reveals two-year-old daughter's flu-like symptoms were deadly meningitis
Restaurant manager Irisa Kelly, 27, of Syracuse, New York, became concerned after noticing her two-year-old daughter Riley had a high fever, lack of energy, and spots all over her body. (Source: the Mail online | Health)
Source: the Mail online | Health - December 28, 2020 Category: Consumer Health News Source Type: news

Is Meningitis Contagious
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 14, 2020 Category: General Medicine Source Type: news

Researchers create gene expression database to gain new insights into pneumococcal infecti
(University of Maryland School of Medicine) Researchers at the University of Maryland School of Medicine published one of the most comprehensive analyses of how genes get expressed during infection (known as a transcriptome). The analyses include three different strains of the bacteria Streptococcus pneumoniae, which causes pneumonia, meningitis and middle-ear infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 14, 2020 Category: Infectious Diseases Source Type: news

Consumer Health: What's the difference between bacterial and viral infections?
Many illnesses, including pneumonia, meningitis and diarrhea, can be caused by either bacteria or viruses. In some cases, it may be difficult to determine which is causing your symptoms. Bacteria are one-celled organisms that can be seen only with a microscope. Not all bacteria are harmful, and some bacteria that live in your body are helpful. However, many bacteria [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 14, 2020 Category: Databases & Libraries Source Type: news

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four tr ials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vac cine or saline). ...
Source: Current Awareness Service for Health (CASH) - December 9, 2020 Category: Consumer Health News Source Type: news

Study shows why some people may become seriously ill from meningococcal bacteria
(Karolinska Institutet) Researchers at Karolinska Institutet in Sweden have come one step closer toward understanding why some people become seriously ill or die from a common bacterium that leaves most people unharmed. In a study published in The Lancet Microbe, the researchers linked RNA mutations within the bacterium Neisseria meningitidis to invasive meningococcal disease, marking the first time a non-coding RNA in a bacterium has been linked to disease progression. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 7, 2020 Category: Infectious Diseases Source Type: news

Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under 18s
Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study from researchers in Portugal and the UK and led by the University of Bristol which evaluated the vaccine ’ s performance in a real-world setting. The findings are published today [1 December] in the Journal of the American Medical Association (JAMA). (Source: University of Bristol news)
Source: University of Bristol news - December 1, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences, Faculty of Life Sciences, Faculty of Life Sciences, School of Cellular and Molecular Medicine; Press Release Source Type: news

Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s
(University of Bristol) Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study from researchers in Portugal and the UK and led by the University of Bristol which evaluated the vaccine's performance in a real-world setting. The findings are published today [1 December] in the Journal of the American Medical Association (JAMA). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2020 Category: International Medicine & Public Health Source Type: news

An AstraZeneca Manufacturing Error Is Clouding Vaccine Study Results
LONDON — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine. A statement describing the error came days after the company and the university described the shots as “highly effective” and made no mention of why some study participants didn’t receive as much vaccine in the first of two shots as expected. In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses. In the low-dose group, AstraZeneca said,...
Source: TIME: Health - November 26, 2020 Category: Consumer Health News Authors: DANICA KIRKA / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news

Potential treatment against antibiotic-resistant bacteria causing gonorrhea and meningitis
(Institut national de la recherche scientifique - INRS) A team from the Institut national de la recherche scientifique (INRS) has demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains of the bacteria responsible for gonorrhea and meningococcal meningitis. These two infections affect millions of people worldwide. The results of this research, led by Professor Fr é d é ric Veyrier and Professor Annie Castonguay, have just been published online in the Antimicrobial Agents and Chemotherapy journal. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 24, 2020 Category: Infectious Diseases Source Type: news

Alzheimer's disease drug may help fight against antibiotic resistance
(University of Queensland) An experimental Alzheimer's disease treatment is proving effective at treating some of the most persistent, life-threatening antibiotic-resistant bacteria. Researchers from The University of Queensland, The University of Melbourne and Griffith University have discovered that the drug called PBT2 is effective at disrupting and killing a class of bacteria - known as Gram-negative bacteria - that cause infections such as pneumonia, bloodstream infections and meningitis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 18, 2020 Category: Infectious Diseases Source Type: news

5 Things to Know About Meningococcal Disease 5 Things to Know About Meningococcal Disease
Should meningococcal disease be considered a medical emergency? Here are five things to know.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - November 11, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

The gut trains the immune system to protect the brain
Gut-trained immune cells at CNS borders guard against meningitis and other infections. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - November 5, 2020 Category: American Health Source Type: news

Two Thirds of US Teens Fail to Get Needed Vaccines Two Thirds of US Teens Fail to Get Needed Vaccines
Completion rates vary from 11.3% in Idaho to 56.4% in Rhode Island. Provider visits at age 16 or 17 and mandates for meningococcal ACWY are keys to uptake, researcher says.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 23, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Vaccination Coverage Among U.S. Adolescents Aged 13-17 Vaccination Coverage Among U.S. Adolescents Aged 13-17
Data in this report indicates that adolescent vaccination coverage in the United States continues to improve for HPV and for meningococcal vaccines, but disparities remain.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 21, 2020 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

EMedHome's Clinical Pearl: Detecting Occult Meningitis with CSF WBC Count
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - October 1, 2020 Category: Emergency Medicine Tags: EMedHome's Clinical Pearl Source Type: news

South Africa: How Changing Vaccine Schedules Can Save Costs and Lives
[The Conversation Africa] In 2005, before most low- and middle-income countries started vaccinating children routinely for pneumococcal disease, it caused approximately 1.5 million deaths worldwide annually. About 700,000 to 1 million of these deaths were in children under five years. Pneumococcal disease occurs when Streptococcus pneumoniae invades a normally sterile area of the body, causing meningitis, pneumonia, septicaemia or other disease syndromes. Case fatality rates are very high for septicaemia (>20%) and meningitis (& (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 29, 2020 Category: African Health Source Type: news

ACIP Provides Recommendations on Meningococcal Vaccination
FRIDAY, Sept. 25, 2020 -- Routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended for adolescents aged 11 to 12 years with a booster at age 16 years, according to a report published in the Sept. 24 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 25, 2020 Category: Pharmaceuticals Source Type: news

The infection that could be more deadly for students than coronavirus
Student Ben de Souza from Burgess Hill, West Sussex, had contracted a particularly aggressive form of meningitis B, a strain responsible for most cases of bacterial meningitis. (Source: the Mail online | Health)
Source: the Mail online | Health - September 21, 2020 Category: Consumer Health News Source Type: news

Massachusetts Has Highest Vaccination Rate In America, Report Says
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4698051","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 15, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Vaccines Source Type: news

New Model Helps Tell Bacterial From Aseptic Meningitis in Kids New Model Helps Tell Bacterial From Aseptic Meningitis in Kids
A new clinical prediction rule, the meningitis score for emergencies, accurately distinguishes bacterial meningitis from aseptic meningitis in children with cerebrospinal fluid pleocytosis.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - August 26, 2020 Category: Pathology Tags: Neurology & Neurosurgery News Source Type: news

'No human wants to take a limb from a child' Jonnie Peacock praises surgeon who amputated his leg
The Paralympian, 27, who won gold in 2012, looked emotional as he heard surgeon Per Hall speaking about the 'very dark days' when Jonnie was admitted to hospital as a five-year-old with meningitis. (Source: the Mail online | Health)
Source: the Mail online | Health - August 26, 2020 Category: Consumer Health News Source Type: news

Children's National Hospital case report sounds the alarm for antibiotic resistance
(Children's National Hospital) A recent meningitis case at Children's National Hospital raises serious concerns about antibiotic resistance in the common bacterium that caused it, researchers from the hospital write in a case report. Their findings, published online August 3 in the Journal of the Pediatric Infectious Disease Society, could change laboratory and clinical practice across the US and potentially around the globe (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 3, 2020 Category: Infectious Diseases Source Type: news

Oxford ’s COVID-19 Vaccine Candidate Takes a Big Leap Forward, Showing Success in Early Trials
The foot race to develop the first effective vaccine against COVID-19 involves an awfully crowded field, with 137 candidate vaccines in pre-clinical study worldwide and another 23 actually in development. But a leader seemed to emerge today with research published in the Lancet reporting promising results in a robust study by investigators at Oxford University in England. The study began in April, with a sample group of 1,077 adults aged 18 to 55—an age group young enough to tolerate exposure to SARS-CoV2, the virus that causes COVID-19, with less risk of adverse effects than would be seen in older, more vulnerable a...
Source: TIME: Health - July 20, 2020 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 Source Type: news

COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and generated robust immune responses against the SARS-CoV-2 virus in all evaluated participants. COV001 is a blinded, multi-centre, randomised controlled Phase I/II trial with 1,077 healthy adult participants, aged 18-55 years. It assessed a single dose of AZD1222 against a comparator meningococcal conjugate vaccine, MenACWY. (Source: World Pharma News)
Source: World Pharma News - July 20, 2020 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Kate Garraway health: 'I couldn't look at the lights' - GMB star reveals shock symptoms
KATE GARRAWAY returns to ITV's Good Morning Britain on Monday morning, after a period away from the TV show to be with her husband, as he continues his recovery from coronavirus. But, the GMB presenter was rushed to hospital herself last year. Would you recognise the signs and symptoms of meningitis? (Source: Daily Express - Health)
Source: Daily Express - Health - July 13, 2020 Category: Consumer Health News Source Type: news

Coronavirus Remains Front and Center at June ACIP Meeting
The CDC's Advisory Committee on Immunization Practices met virtually June 24 to discuss topics related to the COVID-19 pandemic and issues pertaining to vaccines for influenza and meningococcal disease. (Source: AAFP News)
Source: AAFP News - July 1, 2020 Category: Primary Care Source Type: news

Meningococcal disease: laboratory confirmed cases in England in 2019 to 2020, PHE (updated 30th June 2020)
Laboratory confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal surveillance programme in England. 30 June 2020 Added corrected table 1 in January to March 2020 report. 23 June 2020 Added Health Protection Report (HPR) 14(12) January to March 2020 quarterly report. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 30, 2020 Category: Consumer Health News Source Type: news